Stock Earnings

Question 1

Renalytix PLC'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Renalytix PLC'in toplam varlıkları $7 olup, net loss $-45'dir.

Question 2

RNLXY'ün temel finansal oranları nelerdir?

Accepted Answer

Renalytix PLC'in cari oranı 0.43, net kâr marjı -2,250, hisse başına satış $0.01'dir.

Question 3

Renalytix PLC'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Renalytix PLC largest revenue segment is Artificial Intelligence-enabled in Vitro Diagnostics, at a revenue of 1,818,332 in the most earnings release.For geography, United Kingdom is the primary market for Renalytix PLC, at a revenue of 1,818,332.

Question 4

Renalytix PLC kârlı mı?

Accepted Answer

no, son mali tablolara göre Renalytix PLC'in net loss $-45'dir.

Question 5

Renalytix PLC'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Renalytix PLC'in yükümlülüğü 16'dir.

Question 6

Renalytix PLC'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Renalytix PLC'in toplam tedavüldeki hisse sayısı 154.36'dir.

Breakdown	TTM	06/30/2024	06/30/2023	06/30/2022	06/30/2021	06/30/2020
Revenue	2	2	3	2	1	0
Revenue Growth (YoY)	0%	-33%	50%	100%	--	--
Cost of Revenue	1	2	2	2	0	--
Gross Profit	0	0	0	0	0	--
Selling, General & Admin	20	24	34	46	24	8
Research & Development	--	--	--	--	--	--
Operating Expenses	30	30	43	58	33	11
Other Non Operating Income (Expenses)	--	0	0	9	-8	0
Pretax Income	-34	-45	-46	-49	-35	-10
Income Tax Expense	0	0	0	7	-4	-1
Net Income	-34	-45	-46	-56	-31	-9
Net Income Growth	-19%	-2%	-18%	81%	244%	50%
Shares Outstanding (Diluted)	172.2	108.26	82.21	72.86	71.48	59.07
Shares Change (YoY)	79%	32%	13%	2%	21%	57.99%
EPS (Diluted)	-0.2	-0.42	-0.56	-0.77	-0.43	-0.15
EPS Growth	-56.99%	-25%	-28%	79%	177%	-11%
Free Cash Flow	-22	-29	-32	-46	-26	-11
Free Cash Flow Per Share	-0.12	-0.26	-0.38	-0.63	-0.36	-0.18
Gross Margin	0%	0%	0%	0%	0%	--
Operating Margin	-1,500%	-1,500%	-1,400%	-2,850%	-3,200%	0%
Profit Margin	-1,700%	-2,250%	-1,533.33%	-2,800%	-3,100%	0%
Free Cash Flow Margin	-1,100%	-1,450%	-1,066.66%	-2,300%	-2,600%	0%
EBITDA	-29	-28	-40	-55	-30	-10
EBITDA Margin	-1,450%	-1,400%	-1,333.33%	-2,750%	-3,000%	0%
D&A For EBITDA	1	2	2	2	2	1
EBIT	-30	-30	-42	-57	-32	-11
EBIT Margin	-1,500%	-1,500%	-1,400%	-2,850%	-3,200%	0%
Effective Tax Rate	0%	0%	0%	-14.28%	11.42%	10%

Renalytix PLC (RNLXY) Price

RNLXY Stock Price Chart

RNLXY Income

Follow-Up Questions